beta-lactams has been researched along with Hepatic Encephalopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anjur, V; Bajaj, JS; Biggins, SW; Fallon, MB; Garcia-Tsao, G; Hu, C; Iyer, RK; Kamath, PS; Lai, JC; Maliakkal, B; O'Leary, J; Reddy, KR; Saboo, K; Subramanian, RM; Tandon, P; Thacker, LR; Thuluvath, P; Vargas, H; Wong, F | 1 |
| Chowers, M; Krashin, E; Lishner, M; Reisfeld, S | 1 |
2 other study(ies) available for beta-lactams and Hepatic Encephalopathy
| Article | Year |
|---|---|
Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Ascites; beta-Lactams; Clinical Decision Rules; Cohort Studies; End Stage Liver Disease; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hydrothorax; Infections; Kidney Diseases; Lactulose; Liver Cirrhosis; Logistic Models; Machine Learning; Male; Middle Aged; Mortality; Paracentesis; Patient Readmission; Proton Pump Inhibitors; Reproducibility of Results; Rifaximin; ROC Curve; Severity of Illness Index; Support Vector Machine; Water-Electrolyte Imbalance | 2021 |
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Antifungal Agents; Ascites; Ascitic Fluid; beta-Lactams; Candida albicans; Ertapenem; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; Fluconazole; Hepatic Encephalopathy; Hepatitis C; Humans; Liver Cirrhosis; Middle Aged; Paracentesis; Shock, Septic | 2014 |